CC for Chronic Diseases in Children

Phase-Based Progress Estimates
The University of Texas Health Science Center at Houston, Houston, TX
Chronic Diseases in Children+1 More
CC - Other
< 65
All Sexes
What conditions do you have?

Study Summary

The purpose of this study is to assess if the benefits for children with medical complexity (CMC) receiving comprehensive care (CC) in an enhanced medical home can be further improved by enhanced telemedicine program (ETM) provided during clinic hours using mobile devices to measure temperature& oxygen saturation, auscultate the heart & lungs, and view the skin, throat, & tympanic membranes in the home.

Eligible Conditions

  • Chronic Diseases in Children

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Chronic Diseases in Children

Study Objectives

2 Primary · 8 Secondary · Reporting Duration: end of study(about 24 months)

Month 24
All cause infections on admission to the hospital
Cost effectiveness of ETM
Number of days care provided in a medical setting
Parent ratings of care assessed using the Consumer Assessment of Healthcare Providers and Systems Survey
Total number of Pediatric Intensive Care Unit (PICU) days
Total number of deaths
Total number of emergency department visits
Total number of episodes of serious illnesses (causing death, pediatric ICU admission, and hospital stay > 7d).
Total number of hospital days
Total numbers of clinic visits

Trial Safety

Safety Progress

1 of 3

Other trials for Chronic Diseases in Children

Trial Design

2 Treatment Groups

usual CC (with conventional telemedicine)
1 of 2
comprehensive care (CC) augmented with enhanced telemedicine (ETM)
1 of 2
Active Control
Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: CC · No Placebo Group · N/A

comprehensive care (CC) augmented with enhanced telemedicine (ETM)Experimental Group · 2 Interventions: CC, enhanced telemedicine (ETM) · Intervention Types: Other, Device
usual CC (with conventional telemedicine)
ActiveComparator Group · 1 Intervention: CC · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: end of study(about 24 months)
Closest Location: The University of Texas Health Science Center at Houston · Houston, TX
Photo of Houston 1Photo of Houston 2Photo of Houston 3
2008First Recorded Clinical Trial
1 TrialsResearching Chronic Diseases in Children
190 CompletedClinical Trials

Who is running the clinical trial?

Children and Youth with Special Health Care Needs National Research Network (CYSHC)UNKNOWN
The University of Texas Health Science Center, HoustonLead Sponsor
785 Previous Clinical Trials
245,243 Total Patients Enrolled
Ricardo A Mosquera, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
3 Previous Clinical Trials
143 Total Patients Enrolled

Eligibility Criteria

Age < 65 · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.